CXMT shares surge 466% on Shanghai debut in mainland China’s largest IPO since 2010

3 min read
CXMT shares surge 466% on Shanghai debut in mainland China’s largest IPO since 2010
PrimeXBT Editorial Team
Reviewed by PrimeXBT

Topics in article

CXMT shares rose 466% on their Shanghai trading debut, briefly making the memory chipmaker China’s most valuable listed company. The $8.5bn listing is mainland China’s largest since 2010, and it lands as Beijing pushes to build an AI chip supply chain insulated from US export controls.

CXMT shares surged 466% on their trading debut in Shanghai on Monday, briefly turning the memory chipmaker into China’s most valuable company as AI fever gripped the country’s stock market. The stock closed at Rmb49, up from an IPO price of Rmb8.66, lifting the group’s market value to as much as Rmb3.7tn ($547bn) during Monday trading and briefly eclipsing Hong Kong-listed Tencent.

Mainland China’s largest IPO since 2010

The Hefei-based group raised $8.5bn from selling 6.7bn shares, making it mainland China’s largest initial public offering since Agricultural Bank of China in 2010. CXMT holds an option to sell an additional 1bn shares.

Scarcity amplified the move. According to Anna Macdonald, investment strategy director at Hargreaves Lansdown, speaking to the BBC’s Today programme: “only 7% of the shares are available for trading”, and analysts said demand far outstripped supply. The debut also offers comfort to Chinese officials rolling out measures to curb a market slump that wiped out more than $1.5tn in recent weeks.

AI demand flipped the chipmaker to profit

CXMT is the world’s fourth-largest producer of DRam, the chips used in devices from servers to cameras, behind SK Hynix, Samsung Electronics and Micron. A surge in demand from AI inference has triggered shortages and price rises, and the company turned profitable this year, raking in Rmb33bn ($4.9bn) in the first quarter alone after Rmb37bn of losses over the past decade.

Investors paid up for that reversal. The buying pushed CXMT’s price-to-earnings ratio above 1,600. Nomura then initiated coverage with a target price of Rmb116 a share, more than 1,200% above the IPO price.

Export controls still cap the top end

Some investors and analysts warned that as Chinese production increased, memory chip prices could fall, posing a threat to established DRam makers such as Samsung and SK Hynix. CXMT is developing HBM chips but lags global rivals, in large part because US export controls have barred it from accessing the most advanced manufacturing tools from Netherlands-based ASML.

Meanwhile, research firm SemiAnalysis estimated CXMT would have capacity to start 350,000 new wafers a month by the end of this year — close to Micron’s 385,000 — and reach 500,000 by the end of 2028.

Sources: Financial Times, BBC News

Trading involves risk.

Most traded markets

XAU / USD
-0.9% 4,127.61
BRENT
+1.35% 73.620
BTC / USD
+0.7% 63,151.2
EUR / USD
-0.12% 1.14269
USTEC
-0.91% 29,428.7
XAU / USD.24
-0.9% 4,127.61
View all markets

Author

PrimeXBT
Our Editorial Team consists of leading experts with a proven record in the fields of trading, cryptocurrencies, blockchain and finance. We thoroughly research the sources of information in order to provide readers with quality content that serves edu...
Read author’s articles
Alert Triangle Risk Disclaimer
Disclaimer: Some past publications may be outdated. We recommend following our news to stay up to date with the latest information. For any questions, feel free to contact our support team via the chat below.
The content provided here is for informational purposes only. It is not intended as personal investment advice and does not constitute a solicitation or invitation to engage in any financial transactions, investments, or related activities. Past performance is not a reliable indicator of future results.
The financial products offered by the Company are complex and come with a high risk of losing money rapidly due to leverage. These products may not be suitable for all investors. Before engaging, you should consider whether you understand how these leveraged products work and whether you can afford the high risk of losing your money.
The Company does not accept clients from the Restricted Jurisdictions as indicated in our website/ T&C. Some services or products may not be available in your jurisdiction.
The applicable legal entity and its respective products and services depend on the client’s country of residence and the entity with which the client has established a contractual relationship during registration.

Today in markets

Browse Stock News

Register Now

Trading involves risk

Get started in minutes

Our clients love how fast and simple our sign-up is. It takes just a few minutes to get started!

Get Started Get Started
Get started in minutes

Need Help?

Risk Warning:
Trading in leveraged products carries a high level of risk and may not be suitable for all investors.